The platelet as a model system for the acute actions of nuclear receptors

Steroids

Volumn 75, Issue 8-9, 2010, Pages 570-575

  Bishop Bailey, David ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Nuclear receptor; Platelets; PPAR

Indexed keywords

4 HYDROXYTAMOXIFEN; ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; ALDOSTERONE; ALITRETINOIN; ANDROGEN RECEPTOR; ARACHIDONIC ACID; CALCIUM IONOPHORE; CELL NUCLEUS RECEPTOR; CLOPIDOGREL; COLLAGEN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; MEDROXYPROGESTERONE ACETATE; MIFEPRISTONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PREDNISOLONE; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR BETA; RETINOID X RECEPTOR GAMMA; THROMBOXANE A2 RECEPTOR; VON WILLEBRAND FACTOR; CELL RECEPTOR;

ACUTE CORONARY SYNDROME; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CORONARY ARTERY DISEASE; ESTROGEN THERAPY; FATTY ACID OXIDATION; HORMONE SUBSTITUTION; HUMAN; INFLAMMATION; LOW DRUG DOSE; MEGAKARYOCYTE; METASTASIS; NONHUMAN; POSTMENOPAUSE; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; VEIN THROMBOSIS; BIOLOGICAL MODEL; METABOLISM;

BLOOD PLATELETS; HUMANS; MODELS, BIOLOGICAL; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 77954243142     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2009.09.005     Document Type: Conference Paper

References (74)

1. S.P. Watson Platelet activation by extracellular matrix proteins in haemostasis and thrombosis Curr Pharm Des 15 2009 1358 1372
2. K. Kaushansky Historical review: megakaryopoiesis and thrombopoiesis Blood 111 2008 981 986
3. M. Borchert, T. Schondorf, G. Lubben, T. Forst, and A. Pfutzner Review of the pleiotropic effects of peroxisome proliferator-activated receptor gamma agonists on platelet function Diabetes Technol Ther 9 2007 410 420
4. V.M. Miller, M. Jayachandran, K. Hashimoto, J.A. Heit, and W.G. Owen Estrogen, inflammation, and platelet phenotype Gend Med 5 Suppl. A 2008 S91 S102
5. S.L. Spinelli, J.J. O'Brien, S. Bancos, G.M. Lehmann, D.L. Springer, and N. Blumberg The PPAR-platelet connection: modulators of inflammation and potential cardiovascular effects PPAR Res 2008 2008 328172
6. L. Borsig The role of platelet activation in tumor metastasis Expert Rev Anticancer Ther 8 2008 1247 1255
7. H.F. Langer, and M. Gawaz Platelet-vessel wall interactions in atherosclerotic disease Thromb Haemost 99 2008 480 486
8. A.C. Newby Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability Arterioscler Thromb Vasc Biol 28 2008 2108 2114
9. N.E. Barrett, L. Holbrook, S. Jones, W.J. Kaiser, L.A. Moraes, and R. Rana Future innovations in anti-platelet therapies Br J Pharmacol 154 2008 918 939
10. C. Patrono The PGH-synthase system and isozyme-selective inhibition J Cardiovasc Pharmacol 47 Suppl. 1 2006 S1 6
11. G. Born, and C. Patrono Antiplatelet drugs Br J Pharmacol 147 Suppl. 1 2006 S241 S251
12. N.C. Raju, J.W. Eikelboom, and J. Hirsh Platelet ADP-receptor antagonists for cardiovascular disease: past, present and future Nat Clin Pract Cardiovasc Med 5 2008 766 780
13. J.A. Mitchell, F. Ali, L. Bailey, L. Moreno, and L.S. Harrington Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium Exp Physiol 93 2008 141 147
14. M. Johnson, E. Ramey, and P.W. Ramwell Sex and age differences in human platelet aggregation Nature 253 1975 355 357
15. M. Johnson, E. Ramey, and P.W. Ramwell Androgen-mediated sensitivity in platelet aggregation Am J Physiol 232 1977 H381 H385
16. A.A. Ajayi, R. Mathur, and P.V. Halushka Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses Circulation 91 1995 2742 2747
17. K. Matsuda, A. Ruff, T.A. Morinelli, R.S. Mathur, and P.V. Halushka Testosterone increases thromboxane A2 receptor density and responsiveness in rat aortas and platelets Am J Physiol 267 1994 H887 H893
18. R. Pilo, D. Aharony, and A. Raz Testosterone potentiation of ionophore and ADP induced platelet aggregation: relationship to arachidonic acid metabolism Thromb Haemost 46 1981 538 542
19. S. Li, X. Li, J. Li, X. Deng, and Y. Li Inhibition of oxidative-stress-induced platelet aggregation by androgen at physiological levels via its receptor is associated with the reduction of thromboxane A2 release from platelets Steroids 72 2007 875 880
20. G. Khetawat, N. Faraday, M.L. Nealen, K.V. Vijayan, E. Bolton, and S.J. Noga Human megakaryocytes and platelets contain the estrogen receptor beta and androgen receptor (AR): testosterone regulates AR expression Blood 95 2000 2289 2296
21. M. Jayachandran, K. Karnicki, R.S. Miller, W.G. Owen, K.S. Korach, and V.M. Miller Platelet characteristics change with aging: role of estrogen receptor beta J Gerontol A Biol Sci Med Sci 60 2005 815 819
22. M. Jayachandran, and V.M. Miller Human platelets contain estrogen receptor alpha, caveolin-1 and estrogen receptor associated proteins Platelets 14 2003 75 81
23. J. Bar, J. Lahav, M. Hod, Z. Ben-Rafael, I. Weinberger, and J. Brosens Regulation of platelet aggregation and adenosine triphosphate release in vitro by 17beta-estradiol and medroxyprogesterone acetate in postmenopausal women Thromb Haemost 84 2000 695 700
24. L.A. Moraes, M.J. Paul-Clark, A. Rickman, R.J. Flower, N.J. Goulding, and M. Perretti Ligand-specific glucocorticoid receptor activation in human platelets Blood 106 2005 4167 4175
25. S.A. Kliewer, B.M. Forman, B. Blumberg, E.S. Ong, U. Borgmeyer, and D.J. Mangelsdorf Differential expression and activation of a family of murine peroxisome proliferator-activated receptors Proc Natl Acad Sci U S A 91 1994 7355 7359
26. S.A. Kliewer, K. Umesono, D.J. Noonan, R.A. Heyman, and R.M. Evans Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors Nature 358 1992 771 774
27. I. Issemann, and S. Green Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators Nature 347 1990 645 650
28. A.R. Bell, R. Savory, N.J. Horley, A.I. Choudhury, M. Dickins, and T.J. Gray Molecular basis of non-responsiveness to peroxisome proliferators: the guinea-pig PPARalpha is functional and mediates peroxisome proliferator-induced hypolipidaemia Biochem J 332 Pt 3 1998 689 693
29. M. Gottlicher, E. Widmark, Q. Li, and J.A. Gustafsson Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor Proc Natl Acad Sci U S A 89 1992 4653 4657
30. C. Dreyer, G. Krey, H. Keller, F. Givel, G. Helftenbein, and W. Wahli Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors Cell 68 1992 879 887
31. T. Sher, H.F. Yi, O.W. McBride, and F.J. Gonzalez cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor Biochemistry 32 1993 5598 5604
32. R. Mukherjee, L. Jow, D. Noonan, and D.P. McDonnell Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators J Steroid Biochem Mol Biol 51 1994 157 166
33. A. Schmidt, N. Endo, S.J. Rutledge, R. Vogel, D. Shinar, and G.A. Rodan Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids Mol Endocrinol 6 1992 1634 1641
34. F. Chen, S.W. Law, and B.W. O'Malley Identification of two mPPAR related receptors and evidence for the existence of five subfamily members Biochem Biophys Res Commun 196 1993 671 677
35. E.Z. Amri, F. Bonino, G. Ailhaud, N.A. Abumrad, and P.A. Grimaldi Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors J Biol Chem 270 1995 2367 2371
36. M.E. Greene, B. Blumberg, O.W. McBride, H.F. Yi, K. Kronquist, and K. Kwan Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping Gene Expr 4 1995 281 299
37. K.L. Houseknecht, C.A. Bidwell, C.P. Portocarrero, and M.E. Spurlock Expression and cDNA cloning of porcine peroxisome proliferator-activated receptor gamma (PPARγ) Gene 225 1998 89 96
38. K. Hotta, T.A. Gustafson, S. Yoshioka, H.K. Ortmeyer, N.L. Bodkin, and B.C. Hansen Relationships of PPARgamma and PPARgamma2 mRNA levels to obesity, diabetes and hyperinsulinaemia in rhesus monkeys Int J Obes Relat Metab Disord 22 1998 1000 1010
39. H. Keller, C. Dreyer, J. Medin, A. Mahfoudi, K. Ozato, and W. Wahli Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers Proc Natl Acad Sci U S A 90 1993 2160 2164
40. T. Gulick, S. Cresci, T. Caira, D.D. Moore, and D.P. Kelly The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression Proc Natl Acad Sci U S A 91 1994 11012 11016 (Pubitemid 24349615)
41. A. Fredenrich, and P.A. Grimaldi PPAR delta: an uncompletely known nuclear receptor Diabetes Metab 31 2005 23 27
42. A. Fredenrich, and P.A. Grimaldi Roles of peroxisome proliferator- activated receptor delta in skeletal muscle function and adaptation Curr Opin Clin Nutr Metab Care 7 2004 377 381
43. P. Tontonoz, E. Hu, and B.M. Spiegelman Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor Cell 79 1994 1147 1156
44. P. Tontonoz, E. Hu, R.A. Graves, A.I. Budavari, and B.M. Spiegelman mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer Genes Dev 8 1994 1224 1234
45. D. Bishop-Bailey Peroxisome proliferator-activated receptors in the cardiovascular system Br J Pharmacol 129 2000 823 834
46. D. Bishop-Bailey A role for PPARbeta/delta in ocular angiogenesis PPAR Res 2008 2008 825970
47. D. Bishop-Bailey, and K.E. Swales The role of PPARs in the endothelium: implications for cancer therapy PPAR Res 2008 2008 904251
48. L.A. Moraes, L. Piqueras, and D. Bishop-Bailey Peroxisome proliferator-activated receptors and inflammation Pharmacol Ther 110 2006 371 385
49. G. Chinetti, J.C. Fruchart, and B. Staels Peroxisome proliferator- activated receptors: new targets for the pharmacological modulation of macrophage gene expression and function Curr Opin Lipidol 14 2003 459 468
50. C. Grommes, G.E. Landreth, and M.T. Heneka Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists Lancet Oncol 5 2004 419 429
51. D. Bishop-Bailey, and J. Bystrom Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation Pharmacol Ther 2009
52. D. Bishop-Bailey, and J. Wray Peroxisome proliferator-activated receptors: a critical review on endogenous pathways for ligand generation Prostaglandins Other Lipid Mediat 71 2003 1 22
53. J. Wray, and D. Bishop-Bailey Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biology Exp Physiol 93 2008 148 154
54. F.Y. Ali, P.C. Armstrong, A.R. Dhanji, A.T. Tucker, M.J. Paul-Clark, and J.A. Mitchell Antiplatelet actions of statins and fibrates are mediated by PPARs Arterioscler Thromb Vasc Biol 29 2009 706 711
55. F.Y. Ali, S.J. Davidson, L.A. Moraes, S.L. Traves, M. Paul-Clark, and D. Bishop-Bailey Role of nuclear receptor signaling in platelets: antithrombotic effects of PPARbeta FASEB J 20 2006 326 328
56. F. Akbiyik, D.M. Ray, K.F. Gettings, N. Blumberg, C.W. Francis, and R.P. Phipps Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes Blood 104 2004 1361 1368
57. P.F. Bodary, F.B. Vargas, S.A. King, K.L. Jongeward, K.J. Wickenheiser, and D.T. Eitzman Pioglitazone protects against thrombosis in a mouse model of obesity and insulin resistance J Thromb Haemost 3 2005 2149 2153
58. D. Li, K. Chen, N. Sinha, X. Zhang, Y. Wang, and A.K. Sinha The effects of PPAR-gamma ligand pioglitazone on platelet aggregation and arterial thrombus formation Cardiovasc Res 65 2005 907 912
59. M.P. Khanolkar, R.H. Morris, A.W. Thomas, H. Bolusani, A.W. Roberts, and J. Geen Rosiglitazone produces a greater reduction in circulating platelet activity compared with gliclazide in patients with type 2 diabetes mellitus - an effect probably mediated by direct platelet PPARgamma activation Atherosclerosis 197 2008 718 724
60. J.S. Sidhu, D. Cowan, J.A. Tooze, and J.C. Kaski Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces circulating platelet activity in patients without diabetes mellitus who have coronary artery disease Am Heart J 147 2004 e25
61. L.A. Moraes, K.E. Swales, J.A. Wray, A. Damazo, J.M. Gibbins, and T.D. Warner Nongenomic signaling of the retinoid X receptor through binding and inhibiting Gq in human platelets Blood 109 2007 3741 3744
62. 2+-ATPase and mu-calpain activity are altered in type 2 diabetes mellitus and restored by rosiglitazone Circulation 117 2008 52 60
63. R.J. Glynn, E. Danielson, F.A. Fonseca, J. Genest, A.M. Gotto Jr., and J.J. Kastelein A randomized trial of rosuvastatin in the prevention of venous thromboembolism N Engl J Med 360 2009 1851 1861
64. J.J. O'Brien, C.J. Baglole, T.M. Garcia-Bates, N. Blumberg, C.W. Francis, and R.P. Phipps 15-deoxy-delta12, 14 prostaglandin J2-induced heme oxygenase-1 in megakaryocytes regulates thrombopoiesis J Thromb Haemost 7 2009 182 189
65. J.J. O'Brien, S.L. Spinelli, J. Tober, N. Blumberg, C.W. Francis, and M.B. Taubman 15-deoxy-delta12, 14-PGJ2 enhances platelet production from megakaryocytes Blood 112 2008 4051 4060
66. D.M. Ray, S.L. Spinelli, S.J. Pollock, T.I. Murant, J.J. O'Brien, and N. Blumberg Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles Thromb Haemost 99 2008 86 95
67. C. Looze, D. Yui, L. Leung, M. Ingham, M. Kaler, and X. Yao Proteomic profiling of human plasma exosomes identifies PPARgamma as an exosome-associated protein Biochem Biophys Res Commun 378 2009 433 438
68. M. Prokopi, G. Pula, U. Mayr, C. Devue, J. Gallagher, and Q. Xiao Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures Blood 2009
69. A. Chawla, J.J. Repa, R.M. Evans, and D.J. Mangelsdorf Nuclear receptors and lipid physiology: opening the X-files Science 294 2001 1866 1870
70. S.A. Kliewer, K. Umesono, D.J. Mangelsdorf, and R.M. Evans Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling Nature 355 1992 446 449
71. M.A. Harmon, M.F. Boehm, R.A. Heyman, and D.J. Mangelsdorf Activation of mammalian retinoid X receptors by the insect growth regulator methoprene Proc Natl Acad Sci U S A 92 1995 6157 6160
72. R.A. Heyman, D.J. Mangelsdorf, J.A. Dyck, R.B. Stein, G. Eichele, and R.M. Evans 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor Cell 68 1992 397 406
73. A.A. Levin, L.J. Sturzenbecker, S. Kazmer, T. Bosakowski, C. Huselton, and G. Allenby 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha Nature 355 1992 359 361
74. A. von Knethen, M. Soller, N. Tzieply, A. Weigert, A.M. Johann, and C. Jennewein PPARgamma1 attenuates cytosol to membrane translocation of PKCalpha to desensitize monocytes/macrophages J Cell Biol 176 2007 681 694